Chronic Heart Failure Drug Development Pipeline Analysis 2018 – Companies, Drugs, Clinical Trials and Latest Developments in the Chronic Heart Failure Market – ResearchAndMarkets.com

The “2018
Chronic Heart Failure Drug Development Pipeline Analysis Report-
Companies, Drugs, Clinical Trials, Latest Developments in Chronic Heart
Failure Market” report has been added to ResearchAndMarkets.com’s
offering.

The report provides insights into different therapeutic candidates in
preclinical, research, discovery, NDA/IND, pre registration, phase 1,
phase 2, and phase 3 trials). Drugs under development directly and
through combination with other drugs are also included.

Current status, developmental phase, participating companies and
entities, recent developments, orphan drug/ fast track/ other
designations, drug class are provided for each Chronic Heart Failure
pipeline product. Mechanism of Action and the target area of the
pipeline product are also provided. Further, clinical and preclinical
trials along with results of the trials are also included in the report.

In addition to complete details of each product, the report provides key
trends in Chronic Heart Failure pipeline studies. The products under
development are categorized according to their development phase,
mechanism and company to provide detailed insights into the type of
drugs being developed and the stages of development.

Key Topics Covered:

1 Chronic Heart Failure Pipeline Analysis

2 Chronic Heart Failure – Company Wise Pipeline Analysis

3 Chronic Heart Failure R&D Pipeline Snapshots

4 Recent Developments in Chronic Heart Failure Pipeline

5 Appendix

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/research/rfjq5h/chronic_heart?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20180712005412/en/

Leave a Comment